Vicore offers advance voting in connection with the 2020 AGM
Gothenburg, May 4, 2020 – Vicore Pharma Holding AB (publ) hereby informs that the shareholders may exercise their voting rights at the Annual General Meeting 2020 by voting in advance. Vicore encourages all shareholders to use this option in order to minimise the number of participants attending the general meeting in person, as part of the effort to minimise the risk of spreading the coronavirus.
A special form shall be used for advance voting. The form is available on https://vicorepharma.com/wp-content/uploads/2020/04/vicore_pharma_-_agm_2020_-_formulr_fr_frhandsrstning_och_anmlan_eng.pdf
A shareholder who is exercising its voting right through advance voting do not need to notify the company of its attendance to the general meeting. The advance voting form is considered as the notification of attendance to the general meeting.
The completed voting form must be submitted to Vicore no later than Thursday 14 May 2020. The completed and signed form shall be sent to by e-mail to nina.carlen@vicorepharma.com, or by post to Vicore Pharma Holding AB (publ), attn. Nina Carlén, Kronhusgatan 11, SE-411 05 Göteborg, Sweden. If the shareholder is a legal entity, a certificate of incorporation or a corresponding document shall be enclosed to the form. The same apply for shareholders voting in advance by proxy. The shareholder may not provide special instructions or conditions in the voting form. If so, the vote is invalid.
Further instructions and conditions are included in the form for advance voting.
For information about the Annual General Meeting 2020 visit: https://vicorepharma.com/investors/corporate-governance/general-meeting/
For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63, carl-johan.dalsgaard@vicorepharma.com
Source: Vicore Pharma
